Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by Avatarhashon Oct 14, 2019 10:35pm
148 Views
Post# 30229679

RE:2019 Q4 vs 2020 Q1

RE:2019 Q4 vs 2020 Q1If they bring those numbers tomorrow, we gonna have a big short squeeze..37 million in cannabis revenue is a beat
Outhere wrote: Q4
Distribution Rev $99,19mm (euro has since weakened by 5 cents vs CDN)
Net Cannabis Rev $28.61mm
Net Rev $128.57mm

Q1
Distribution Rev $94.23 (keep the same but impact due to FX)
Net Cannabis Rev $37.19 (30% increase in sales from last quarter due to Canntrust, APH 1-4 licensed).
Net Rev $131.42mm


Bullboard Posts